Indications
Rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.
Composition
- Active substance
- fostemsavir trometamol
- International name (INN)
- fostemsavir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rukobia
- Active substance
- fostemsavir trometamol
- ATC code
- J05AX
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- ViiV Healthcare B.V.